The march of pluripotent stem cells in cardiovascular regenerative medicine
Abstract Cardiovascular disease (CVD) continues to be the leading cause of global morbidity and mortality. Heart failure remains a major contributor to this mortality. Despite major therapeutic advances over the past decades, a better understanding of molecular and cellular mechanisms of CVD as well...
Main Authors: | Haissam Abou-Saleh, Fouad A. Zouein, Ahmed El-Yazbi, Despina Sanoudou, Christophe Raynaud, Christopher Rao, Gianfranco Pintus, Hassan Dehaini, Ali H. Eid |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-0947-5 |
Similar Items
-
A generally conserved response to hypoxia in iPSC-derived cardiomyocytes from humans and chimpanzees
by: Michelle C Ward, et al.
Published: (2019-04-01) -
Getting to the heart of cardiovascular evolution in humans
by: Alex Pollen, et al.
Published: (2019-05-01) -
Versatility of Induced Pluripotent Stem Cells (iPSCs) for Improving the Knowledge on Musculoskeletal Diseases
by: Clara Sanjurjo-Rodríguez, et al.
Published: (2020-08-01) -
A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses
by: Marcela K. Preininger, et al.
Published: (2016-09-01) -
CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes
by: John W. Ostrominski, et al.
Published: (2020-10-01)